A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth

This study is currently recruiting participants.
Verified February 2012 by KV Pharmaceutical Company
Sponsor:
Collaborator:
Registrat-Mapi
Information provided by (Responsible Party):
KV Pharmaceutical Company
ClinicalTrials.gov Identifier:
NCT01146990
First received: June 16, 2010
Last updated: January 14, 2014
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: June 2016 (Final data collection date for primary outcome measure)